Abstract
In patients with first episode Clostridium difficile infection treated with vancomycin or fidaxomicin, more patients receiving fidaxomicin achieved at least 2 log10 colony-forming units/g reduction in spores at the follow-up visit (P=.02). Similar to published literature, a higher proportion of patients receiving fidaxomicin demonstrated sustained clinical response.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aminoglycosides / pharmacology*
-
Anti-Bacterial Agents / pharmacology*
-
Clostridioides difficile / drug effects*
-
Colony Count, Microbial
-
Connecticut
-
Enterocolitis, Pseudomembranous / drug therapy*
-
Feces / microbiology
-
Female
-
Fidaxomicin
-
Humans
-
Male
-
Middle Aged
-
Polymerase Chain Reaction
-
Vancomycin / pharmacology*
Substances
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Vancomycin
-
Fidaxomicin